Skip to content

Clinical trials

Phase 3 Small Cell Lung Carcinoma trials in Spain

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Small Cell Lung Carcinoma Phase: Phase 3 Country / region: Spain Clear all

36 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20021
20061
20071
20111
20162
20174
20182
20202
20211
20223
20232
20243
20257
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Active, not recruiting11
Recruiting10
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen4
AbbVie3
AstraZeneca3
Hoffmann-La Roche3
Merck Sharp & Dohme LLC3
Bristol-Myers Squibb2
GlaxoSmithKline2
PharmaMar2
BioNTech SE1
Boehringer Ingelheim1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Small Cell Lung Carcinoma36
Lung Neoplasms6
Neoplasms2
Carcinoma1
Carcinoma, Non-Small-Cell Lung1
Carcinoma, Small Cell1
Neoplasm Metastasis1

Trials

Showing 1 to 25 of 36. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.